BioTelemetry maintains market leadership in remote cardio diagnostics through proprietary technology and strong customer relationships. As part of Philips, it benefits from integrated distribution networks and access to broader healthcare solutions, positioning it to expand bundled remote monitoring and cardiac care offerings across enterprise healthcare systems.
Cyborg Score Rationale
BioTelemetry demonstrates solid market positioning in remote cardiac monitoring with established revenue streams and a presence across multiple continents. Ownership by Philips provides financial stability and integration opportunities, though independent growth metrics are limited post-acquisition.
Top Insights
(March 2026) Annual revenue estimated at $179M with 614 employees across 4 continents
(2021) Strategic acquisition by Philips significantly expanded cardiac care offerings and market integration
Founded 25 years ago with leadership in mobile and wireless medical technology
Specializes in remote monitoring solutions and clinical research for cardiac and imaging applications
Named Competitors
Remote Patient Monitoring Solutions — Connected cardiac care and patient monitoring
Connected Care Services — Integrated cardiac device and monitoring solutions